LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX), a specialty pharmaceutical company and an undisclosed ophthalmic company have entered into a five year supply agreement for an ophthalmic product. Akorn is the ANDA holder of the product.
